To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.

Bill: 114-hr-6348
Sponsor: full_name: Rep. Grayson, Alan [D-FL-9]
Introduced: 2016-11-17
Policy area: Health
Latest action: action_date: 2016-11-17
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2016-11-17
action_desc: Introduced in House
text: <p>This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2018 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.)</p>

tv_txt: I 114th CONGRESS 2d Session H. R. 6348 IN THE HOUSE OF REPRESENTATIVES November 17, 2016 Mr. Grayson introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.

1. Extension of program for priority review to encourage treatments for rare pediatric diseases Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360ff(b)(5) ) is amended by striking December 31, 2016 and inserting December 31, 2018 .